Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer-Reference-Cited by-同舟云学术

Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer

Published:2024-05 Issue: Volume:126 Page:102723
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

D'Agostino Elisa,Mastrodomenico Luciana,Ponzoni Ornella,Baldessari Cinzia,Piombino Claudia,Pipitone Stefania,Giuseppa Vitale Maria,Sabbatini Roberto,Dominici Massimo,Toss Angela

Publisher

Elsevier BV

Reference152 articles.

1. Siegel Rebecca L et al. Cancer Statistics, 2022.” CA: A Cancer Journal for Clinicians 2022;72,1:7-33. Doi:10.3322/Caac.21708.

2. Morice Philippe et al. “Endometrial Cancer.” Lancet (London, England) Vol. 387,10023 (2016): 1094-1108. Doi:10.1016/S0140-6736(15)00130-0.

3. Koskas Martin et al. “Cancer of the Corpus Uteri: 2021 Update.” Int J Gynaecol Obstetr: Off Organ Int Federat Gynaecol Obstetr 2021;155(Suppl 1):45-60. Doi:10.1002/Ijgo.13866.

4. Racial disparities in molecular subtypes of endometrial cancer;Dubil;Gynecol Oncol,2018

5. Predictors of survival after recurrence in women with early-stage endometrial carcinoma;Xu;Int J Gynecol Can: Off J Int Gynecol Canc Soc,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated expression of ECT2 as a diagnostic marker and prognostic indicator in endometrial cancer;Gene;2024-11

2. Genetic variation perspective reveals potential drug targets for subtypes of endometrial cancer;2024-07-03

3. Comprehensive Review of Uterine Leiomyosarcoma: Pathogenesis, Diagnosis, Prognosis, and Targeted Therapy;Cells;2024-06-26

4. Copy number variations in endometrial cancer: from biological significance to clinical utility;International Journal of Gynecologic Cancer;2024-04-27